Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04209205
Brief Title: Study to Demonstrate the Efficacy, Safety and Tolerability of Intravenous Secukinumab up to 52 Weeks in Subjects With Active Psoriatic Arthritis (INVIGORATE 2)

First Submitted : October 30, 2019
First Submitted that Met QC Criteria : December 19, 2019
First Posted : December 24, 2019

Last Update Submitted that Met QC Criteria : May 10, 2021
Last Update Posted : May 11, 2021